off label drugs

Join us for an in-depth discussion with FDA Center Directors including Drs. Peter Marks, Susan Mayne, Jeffrey Shuren, and Janet Woodcock on how Public-Private Partnerships can help FDA address its most pressing priorities. Michael McCaughan, Co-Founder of Prevision Policy, will moderate the panel at the Reagan-Udall Foundation for the FDA’s 2019 Annual Public Meeting.